Official UK procurement notice
The Provision of Blood Stem Cell Products
Authority: University Hospitals Plymouth (Central government)
What is being bought
Published requirement descriptionThe provision of Cell products, including Haematopoietic Stem Cells, Bone Marrow Stem Cells and Lymphocytes Transplants
CPV: Services provided by transplant organ banks
The lotProcurement structure
single lot · no lot value publishedLot #1This contract has been awarded using Direct Award Process A under the Provider…Awarded
This contract has been awarded using Direct Award Process A under the Provider Selection Regime (PSR), in accordance with Regulation 7.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 25 Jun 2025, 15:20 BST
- Last source update
- 25 Jun 2025, 15:20 BST
- FTS notice number
2025/S 000-035145- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-055392Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
As per description above, direct award process A under the PSR regulations.
Publisher note: This contract has been awarded using Direct Award Process A under the Provider Selection Regime (PSR), in accordance with Regulation 7.<br/>The decision to award directly is based on the following criteria being met:<br/>The service is currently being delivered by the same provider.<br/>There is no realistic alternative provider capable of delivering the service to the required standard.<br/>The service is not part of a framework agreement.<br/>The provider has demonstrated consistent delivery of high-quality care and continuity is essential to maintain patient safety and service outcomes.<br/>This notice is published for transparency purposes only and does not constitute a call for competition. Estimated contract value is based on three year duration. <br/>The award decision makers include procurement and the regulatory and accreditation manager from the clinical haematology, immunology and oncology department. The contract for these services shall be in place for a minimum of three years. <br/>No declared conflicts or potential conflicts of interests were raised and key decision makers confirmed this by signature.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Anthony Nolan | — | — | Awarded |
Contracts
Contract 035145-2025-1 · Anthony Nolan
- Signed
- 13 May 2025
- Value
- —
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | £1,125,000 – £1,125,000 |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Centre for Effective Dispute ResolutionMediation bodyReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- Anthony NolanAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.